Novartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. He speaks with Bloomberg's Guy Johnson, Kriti Gupta, and Anna Edwards

Stew Leonard’s Wines & Spirits President Blake Leonard Talks Beverage Industry, Company Succession
08:03

Bob Hormats Talks Trump/Xi Summit
08:52

US Trade Representative Jamieson Greer Talks China Trade
13:52